<- Go home

Added to YB: 2023-09-20

Pitch date: 2023-09-20

LQDA:US [bullish]

Liquidia Corporation

+449.68%

current return

Author Info

No bio for this author

Company Info

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.

Market Cap

$2.4B

Pitch Price

$6.22

Price Target

N/A

Dividend

N/A

EV/EBITDA

-23.66

P/E

-19.31

EV/Sales

35.84

Sector

Pharmaceuticals

Category

N/A

Show full summary:
Liquidia Corporation LQDA:US

A summary for this pitch has not been created yet.

Read full article (0 min)